Print Page     Close Window     

SEC Filings

SERES THERAPEUTICS, INC. filed this Form 8-K on 10/16/2017
Entire Document

Slide 11

Clinical Remission is now recommended by FDA as the primary endpoint for UC registrational studies “We currently recommend a primary endpoint of clinical remission (responder definition based on Stool Frequency, Rectal Bleeding, and Endoscopy scores).” Clinical Remission is based on objective endoscopy measure, not subjective as would be Clinical Response FDA Ulcerative colitis draft 2016 guidance: Clinical Trial Endpoints – Guidance for Industry Ulcerative Colitis: Clinical Trial Endpoints Guidance for Industry1

© Seres Therapeutics. All Rights Reserved.